Tag: TLMDx2020

All Podcast Categories
The Newer Diabetes Drugs and Patients with NASH

S2-E7 – The Newer Diabetes Drugs and Patients with NASH

Jörn Schattenberg and Fatty Liver Foundation President Wayne Eskridge join Louise and Roger to consider the current and future roles that GLP-1 receptor agonists like semaglutide and SGLT-2 inhibitors like Jardiance in treating NASH patients.

Episode 40 - Links Between NAFLD And Cardiovascular Disease

Links between NAFLD and Cardiovascular Disease

Dr Ian Rowe and Prof. Dr. Jörn M. Schattenberg joins the Surfers to explore the relationship between NAFLD and CVD in light of recent work questioning the strength of links between the two

Stay In Touch with Surfing NASH

Stay In Touch
  • Name
  • Email & NPI
  • Country
  • Institution & Profession